Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Downregulation of MHC Class I Expression by Influenza A and B Viruses.

Koutsakos M, McWilliam HEG, Aktepe TE, Fritzlar S, Illing PT, Mifsud NA, Purcell AW, Rockman S, Reading PC, Vivian JP, Rossjohn J, Brooks AG, Mackenzie JM, Mintern JD, Villadangos JA, Nguyen THO, Kedzierska K.

Front Immunol. 2019 May 29;10:1158. doi: 10.3389/fimmu.2019.01158. eCollection 2019.

2.

Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.

Farrukee R, Butler J, Reading PC, Hurt AC.

Antiviral Res. 2019 Aug;168:68-75. doi: 10.1016/j.antiviral.2019.05.009. Epub 2019 May 25.

PMID:
31132385
3.

Unraveling the role of the MOV10 RNA helicase during influenza A virus infection.

Villalón-Letelier F, Reading PC.

Biochem J. 2019 Mar 27;476(6):1005-1008. doi: 10.1042/BCJ20190018.

PMID:
30918067
4.

Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection.

Bedford JG, O'Keeffe M, Reading PC, Wakim LM.

PLoS One. 2019 Jan 16;14(1):e0210132. doi: 10.1371/journal.pone.0210132. eCollection 2019.

5.

Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection Ex Vivo.

Ma JZ, Ng WC, Zappia L, Gearing LJ, Olshansky M, Pham K, Cheong K, Hsu A, Turner SJ, Wijburg O, Londrigan SL, Brooks AG, Reading PC.

J Virol. 2019 Mar 5;93(6). pii: e01986-18. doi: 10.1128/JVI.01986-18. Print 2019 Mar 15.

6.

MAIT cells contribute to protection against lethal influenza infection in vivo.

van Wilgenburg B, Loh L, Chen Z, Pediongco TJ, Wang H, Shi M, Zhao Z, Koutsakos M, Nüssing S, Sant S, Wang Z, D'Souza C, Jia X, Almeida CF, Kostenko L, Eckle SBG, Meehan BS, Kallies A, Godfrey DI, Reading PC, Corbett AJ, McCluskey J, Klenerman P, Kedzierska K, Hinks TSC.

Nat Commun. 2018 Nov 9;9(1):4706. doi: 10.1038/s41467-018-07207-9.

7.

CSF3R/CD114 mediates infection-dependent transition to severe asthma.

Wang H, FitzPatrick M, Wilson NJ, Anthony D, Reading PC, Satzke C, Dunne EM, Licciardi PV, Seow HJ, Nichol K, Adcock IM, Chung KF, Anderson GP, Vlahos R, Wark P, Bozinovski S.

J Allergy Clin Immunol. 2019 Feb;143(2):785-788.e6. doi: 10.1016/j.jaci.2018.10.001. Epub 2018 Oct 9. No abstract available.

8.

Changes in Gut Microbiota Prior to Influenza A Virus Infection Do Not Affect Immune Responses in Pups or Juvenile Mice.

Fuglsang E, Pizzolla A, Krych L, Nielsen DS, Brooks AG, Frøkiær H, Reading PC.

Front Cell Infect Microbiol. 2018 Sep 12;8:319. doi: 10.3389/fcimb.2018.00319. eCollection 2018.

9.

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.

Farrukee R, Zarebski AE, McCaw JM, Bloom JD, Reading PC, Hurt AC.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01081-18. doi: 10.1128/AAC.01081-18. Print 2018 Nov.

10.

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Korenkov DA, Laurie KL, Reading PC, Carolan LA, Chan KF, Isakova-Sivak II, Smolonogina TA, Subbarao K, Barr IG, Villanueva J, Shcherbik S, Bousse T, Rudenko LG.

Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19.

11.

Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.

Chan KF, Carolan LA, Korenkov D, Druce J, McCaw J, Reading PC, Barr IG, Laurie KL.

J Infect Dis. 2018 Jul 2;218(3):406-417. doi: 10.1093/infdis/jiy184.

PMID:
29746640
12.

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Laurie KL, Horman W, Carolan LA, Chan KF, Layton D, Bean A, Vijaykrishna D, Reading PC, McCaw JM, Barr IG.

J Infect Dis. 2018 Jan 30;217(4):548-559. doi: 10.1093/infdis/jix509.

13.

Host Cell Restriction Factors that Limit Influenza A Infection.

Villalón-Letelier F, Brooks AG, Saunders PM, Londrigan SL, Reading PC.

Viruses. 2017 Dec 7;9(12). pii: E376. doi: 10.3390/v9120376. Review.

14.

Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.

Chan KF, Carolan LA, Druce J, Chappell K, Watterson D, Young P, Korenkov D, Subbarao K, Barr IG, Laurie KL, Reading PC.

J Virol. 2018 Jan 30;92(4). pii: e01322-17. doi: 10.1128/JVI.01322-17. Print 2018 Feb 15.

15.

The first external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region, 2016.

Reading PC, Leung VK, Buettner I, Gillespie L, Deng YM, Shaw R, Spirason N, Todd A, Shah AS, Konings F, Barr IG.

J Clin Virol. 2017 Dec;97:54-58. doi: 10.1016/j.jcv.2017.10.018. Epub 2017 Nov 2.

PMID:
29127947
16.

Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators In Vitro and In Vivo.

Coppo MJC, Devlin JM, Legione AR, Vaz PK, Lee SW, Quinteros JA, Gilkerson JR, Ficorilli N, Reading PC, Noormohammadi AH, Hartley CA.

J Virol. 2017 Dec 14;92(1). pii: e01534-17. doi: 10.1128/JVI.01534-17. Print 2018 Jan 1.

17.

Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitude.

Quinn KM, Kan WT, Watson KA, Liddicoat BJ, Swan NG, McQuilten H, Denton AE, Li J, Chen W, Brown LE, Jackson DC, Reading PC, Doherty PC, Kedzierska K, Kedzierski L, Turner SJ, La Gruta NL.

PLoS One. 2017 Sep 8;12(9):e0184732. doi: 10.1371/journal.pone.0184732. eCollection 2017.

18.

Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection.

Pizzolla A, Nguyen THO, Smith JM, Brooks AG, Kedzieska K, Heath WR, Reading PC, Wakim LM.

Sci Immunol. 2017 Jun 2;2(12). pii: eaam6970. doi: 10.1126/sciimmunol.aam6970.

PMID:
28783656
19.

Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.

To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, Chan C, Drummond GR, Sobey CG, Broughton BRS, Starkey MR, van der Sluis R, Lewin SR, Bozinovski S, O'Neill LAJ, Quach T, Porter CJH, Brooks DA, O'Leary JJ, Selemidis S.

Nat Commun. 2017 Jul 12;8(1):69. doi: 10.1038/s41467-017-00057-x.

20.

Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.

Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC, Wakim LM.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):5225-5230. doi: 10.1073/pnas.1620194114. Epub 2017 May 1.

21.

Pattern recognition receptor immunomodulation of innate immunity as a strategy to limit the impact of influenza virus.

Pizzolla A, Smith JM, Brooks AG, Reading PC.

J Leukoc Biol. 2017 Apr;101(4):851-861. doi: 10.1189/jlb.4MR0716-290R. Epub 2016 Nov 3. Review.

PMID:
27810944
22.

DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.

Gillespie L, Gerstenberg K, Ana-Sosa-Batiz F, Parsons MS, Farrukee R, Krabbe M, Spann K, Brooks AG, Londrigan SL, Reading PC.

J Virol. 2016 Aug 12;90(17):7848-63. doi: 10.1128/JVI.00537-16. Print 2016 Sep 1.

23.

Neutralizing inhibitors in the airways of naïve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses.

Job ER, Pizzolla A, Nebl T, Short KR, Deng YM, Carolan L, Laurie KL, Brooks AG, Reading PC.

Virology. 2016 Jul;494:143-57. doi: 10.1016/j.virol.2016.01.024. Epub 2016 Apr 26.

24.

Neonatal pneumococcal colonisation caused by Influenza A infection alters lung function in adult mice.

FitzPatrick M, Royce SG, Langenbach S, McQualter J, Reading PC, Wijburg O, Anderson GP, Stewart A, Bourke J, Bozinovski S.

Sci Rep. 2016 Mar 4;6:22751. doi: 10.1038/srep22751.

25.

Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN.

Gillespie L, Roosendahl P, Ng WC, Brooks AG, Reading PC, Londrigan SL.

Sci Rep. 2016 Jan 14;6:19428. doi: 10.1038/srep19428.

26.

Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming.

Infusini G, Smith JM, Yuan H, Pizzolla A, Ng WC, Londrigan SL, Haque A, Reading PC, Villadangos JA, Wakim LM.

PLoS One. 2015 Nov 23;10(11):e0143539. doi: 10.1371/journal.pone.0143539. eCollection 2015.

27.

Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection.

Londrigan SL, Tate MD, Job ER, Moffat JM, Wakim LM, Gonelli CA, Purcell DF, Brooks AG, Villadangos JA, Reading PC, Mintern JD.

PLoS One. 2015 Nov 13;10(11):e0142925. doi: 10.1371/journal.pone.0142925. eCollection 2015.

28.

Pentraxins and Collectins: Friend or Foe during Pathogen Invasion?

Foo SS, Reading PC, Jaillon S, Mantovani A, Mahalingam S.

Trends Microbiol. 2015 Dec;23(12):799-811. doi: 10.1016/j.tim.2015.09.006. Epub 2015 Oct 17. Review.

PMID:
26482345
29.

Differential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma.

Tang FS, Van Ly D, Spann K, Reading PC, Burgess JK, Hartl D, Baines KJ, Oliver BG.

Respirology. 2016 Jan;21(1):172-9. doi: 10.1111/resp.12657. Epub 2015 Oct 18.

30.

The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus.

Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG, Reading PC.

J Virol. 2015 Oct 14;90(1):206-21. doi: 10.1128/JVI.01447-15. Print 2016 Jan 1.

31.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

32.

Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Mifsud EJ, Tan AC, Reading PC, Jackson DC.

Immunol Cell Biol. 2016 Feb;94(2):169-76. doi: 10.1038/icb.2015.81. Epub 2015 Aug 14.

PMID:
26272554
33.

Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses.

Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, Chua BY, Sun Y, Tang L, Handel A, Jackson DC, Turner SJ, Thomas PG, Kedzierska K.

PLoS One. 2015 Jun 18;10(6):e0129768. doi: 10.1371/journal.pone.0129768. eCollection 2015.

34.

Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation.

Foo SS, Chen W, Taylor A, Sheng KC, Yu X, Teng TS, Reading PC, Blanchard H, Garlanda C, Mantovani A, Ng LF, Herrero LJ, Mahalingam S.

PLoS Pathog. 2015 Feb 19;11(2):e1004649. doi: 10.1371/journal.ppat.1004649. eCollection 2015 Feb. Erratum in: PLoS Pathog. 2015 Apr;11(4):e1004797.

35.

Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.

Jegaskanda S, Reading PC, Kent SJ.

J Immunol. 2014 Jul 15;193(2):469-75. doi: 10.4049/jimmunol.1400432. Review.

36.

Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.

Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S, Reading PC.

Viruses. 2014 Mar 14;6(3):1294-316. doi: 10.3390/v6031294. Review.

37.

A Novel Method Linking Antigen Presentation by Human Monocyte-Derived Macrophages to CD8(+) T Cell Polyfunctionality.

Short KR, Grant EJ, Vissers M, Reading PC, Diavatopoulos DA, Kedzierska K.

Front Immunol. 2013 Nov 21;4:389. doi: 10.3389/fimmu.2013.00389. eCollection 2013.

38.

A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice.

Job ER, Bottazzi B, Short KR, Deng YM, Mantovani A, Brooks AG, Reading PC.

J Immunol. 2014 Jan 1;192(1):271-81. doi: 10.4049/jimmunol.1301814. Epub 2013 Dec 4.

39.

The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus.

Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL, Reading PC.

J Virol. 2014 Feb;88(3):1659-72. doi: 10.1128/JVI.02014-13. Epub 2013 Nov 20.

40.

Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media.

Short KR, von Köckritz-Blickwede M, Langereis JD, Chew KY, Job ER, Armitage CW, Hatcher B, Fujihashi K, Reading PC, Hermans PW, Wijburg OL, Diavatopoulos DA.

Infect Immun. 2014 Jan;82(1):364-70. doi: 10.1128/IAI.01104-13. Epub 2013 Nov 4.

41.

Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC, Kent SJ.

J Virol. 2013 Dec;87(24):13706-18. doi: 10.1128/JVI.01666-13. Epub 2013 Oct 9.

42.

Bacterial lipopolysaccharide inhibits influenza virus infection of human macrophages and the consequent induction of CD8+ T cell immunity.

Short KR, Vissers M, de Kleijn S, Zomer AL, Kedzierska K, Grant E, Reading PC, Hermans PW, Ferwerda G, Diavatopoulos DA.

J Innate Immun. 2014;6(2):129-39. doi: 10.1159/000353905. Epub 2013 Aug 20.

43.

Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.

Jegaskanda S, Laurie KL, Amarasena TH, Winnall WR, Kramski M, De Rose R, Barr IG, Brooks AG, Reading PC, Kent SJ.

J Infect Dis. 2013 Oct 1;208(7):1051-61. doi: 10.1093/infdis/jit294. Epub 2013 Jun 28.

PMID:
23812238
44.

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.

Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL.

PLoS Pathog. 2013;9(5):e1003354. doi: 10.1371/journal.ppat.1003354. Epub 2013 May 9.

45.

Influenza A virus induced bacterial otitis media is independent of virus tropism for α2,6-linked sialic acid.

Short KR, Habets MN, Payne J, Reading PC, Diavatopoulos DA, Wijburg OL.

Virol J. 2013 Apr 23;10:128. doi: 10.1186/1743-422X-10-128.

46.

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Job ER, Bottazzi B, Gilbertson B, Edenborough KM, Brown LE, Mantovani A, Brooks AG, Reading PC.

PLoS One. 2013;8(3):e59623. doi: 10.1371/journal.pone.0059623. Epub 2013 Mar 27.

47.

Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.

Job ER, Deng YM, Barfod KK, Tate MD, Caldwell N, Reddiex S, Maurer-Stroh S, Brooks AG, Reading PC.

J Immunol. 2013 Mar 1;190(5):2169-77. doi: 10.4049/jimmunol.1202433. Epub 2013 Jan 30.

48.

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, Winnall WR, Stratov I, Brooks AG, Reading PC, Kent SJ.

J Immunol. 2013 Feb 15;190(4):1837-48. doi: 10.4049/jimmunol.1201574. Epub 2013 Jan 14.

49.

Influenza-induced inflammation drives pneumococcal otitis media.

Short KR, Reading PC, Brown LE, Pedersen J, Gilbertson B, Job ER, Edenborough KM, Habets MN, Zomer A, Hermans PW, Diavatopoulos DA, Wijburg OL.

Infect Immun. 2013 Mar;81(3):645-52. doi: 10.1128/IAI.01278-12. Epub 2013 Jan 14.

50.

The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.

Inforzato A, Reading PC, Barbati E, Bottazzi B, Garlanda C, Mantovani A.

Front Immunol. 2013 Jan 7;3:407. doi: 10.3389/fimmu.2012.00407. eCollection 2012.

Supplemental Content

Loading ...
Support Center